Koramannil Radha Saradalekshmi

Koramannil Radha Saradalekshmi

Auto-generated profile, based on publicly available information

Koramannil Radha Saradalekshmi

Human Molecular Genetics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKoramannil Radha Saradalekshmi
Koramannil Radha Saradalekshmi
NNNanoth Vellichiramal Neetha
Nanoth Vellichiramal Neetha
SSSanish Sathyan
Sanish Sathyan
INIndu V. Nair
Indu V. Nair
CNChandrasekharan M. Nair
Chandrasekharan M. Nair
MBMoinak Banerjee
Moinak Banerjee
DNA methylation has been implicated in the etiopathology of various complex disorders. DNA methyltransferases are involved in maintaining and establishing new methylation patterns. The aim of the present study was to investigate the inherent genetic variations within DNA methyltransferase genes in predisposing to susceptibility to schizophrenia. We screened for polymorphisms in DNA methyltransferases, DNMT1, DNMT3A, DNMT3B and DNMT3L in 330 schizophrenia patients and 302 healthy controls for association with Schizophrenia in south Indian population. These polymorphisms were also tested for subgroup analysis with patient's gender, age of onset and family history. DNMT1 rs2114724 (genotype P = .004, allele P = 0.022) and rs2228611 (genotype P = 0.004, allele P = 0.022) were found to be significantly associated at genotypic and allelic level with Schizophrenia in South Indian population. DNMT3B rs2424932 genotype (P = 0.023) and allele (P = 0.0063) increased the risk of developing schizophrenia in males but not in females. DNMT3B rs1569686 (genotype P = 0.027, allele P = 0.033) was found to be associated with early onset of schizophrenia and also with family history and early onset (genotype P = 0.009). DNMT3L rs2070565 (genotype P = 0.007, allele P = 0.0026) confers an increased risk of developing schizophrenia at an early age in individuals with family history. In-silico prediction indicated functional relevance of these SNPs in regulating the gene. These observations might be crucial in addressing and understanding the genetic control of methylation level differences from ethnic viewpoint. Functional significance of genotype variations within the DNMTs indeed suggest that the genetic nature of methyltransferases should be considered while addressing epigenetic events mediated by methylation in Schizophrenia.

1 November 2013 in Pharmacogenetics and Genomics
Verified
Journal Article
Closed access
SBShabeesh Balan
Shabeesh Balan
SSSanish Sathyan
Sanish Sathyan
SRSaradalekshmi K. Radha
Saradalekshmi K. Radha
VJVijai Joseph
Vijai Joseph
KRKurupath Radhakrishnan
Kurupath Radhakrishnan
MBMoinak Banerjee
Moinak Banerjee
Objective Several antiepileptic drugs (AEDs) are known to target the GABAA receptor through positive allosteric modulation of the receptors, thereby enhancing GABAA receptor-mediated inhibition. The large diversity of GABAA receptors has been reported in the central nervous system; some of these have been implicated in epilepsy susceptibility and AED resistance, which we aimed to examine. Materials and methods We investigated the association of single-nucleotide polymorphisms in GABAA receptor subunit subtype genes namely; rs2279020 (GABRA1), rs3219151 (GABRA6), rs2229944 (GABRB2), and rs211037 (GABRG2) with predisposition to epilepsy and AED resistance. This was assessed in three cohorts of ethnically matched South Indian ancestry: mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) (prototype of AED-resistant epilepsy syndrome), juvenile myoclonic epilepsy (prototype of AED-responsive epilepsy syndrome), and nonepilepsy controls. Results A significant allelic (P=0.0006, odds ratio=1.6, 95% confidence interval=1.22–2.08) and genotypic (P=0.001) association of a synonymous variant in GABRG2, rs211037 (Asn196Asn) was observed with epilepsy irrespective of its phenotype, that is, MTLE-HS or juvenile myoclonic epilepsy. However, this association was not retained in epilepsy patients with a history of febrile seizures. The GABAA receptor subunit subtype genes were not found to have any association with AED resistance. In-silico analysis indicated that rs211037 plays a significant role in the transcriptional regulation and splicing regulation. Conclusion We could substantiate that among the GABAA receptor subunit gene cluster polymorphisms, the GABRG2, rs211037 predisposes susceptibility to epilepsy, irrespective of its phenotype, but not to AED resistance.

1 September 2013 in Gene
Verified
Journal Article
Closed access
SBShabeesh Balan
Shabeesh Balan
SLSarada Lekshmi
Sarada Lekshmi
KRKoramannil Radha
Koramannil Radha
SSSanish Sathyan
Sanish Sathyan
VJVijai Joseph
Vijai Joseph
KRKurupath Radhakrishnan
Kurupath Radhakrishnan

8 February 2014 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
BPBasil Paul
Basil Paul
KSK. R. Saradalekshmi
K. R. Saradalekshmi
AAAnn Mary Alex
Ann Mary Alex
MBMoinak Banerjee
Moinak Banerjee

25 September 2013 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SSSanish Sathyan
Sanish Sathyan
LKLinda Koshy
Linda Koshy
KLK. R. Sarada Lekshmi
K. R. Sarada Lekshmi
HEH. V. Easwer
H. V. Easwer
SPS. Premkumar
S. Premkumar
MBMoinak Banerjee
Moinak Banerjee